Progress towards safer and more effective radical cure of Plasmodium vivax

Plasmodium vivax causes a substantial burden of disease in the Americas, the Horn of Africa, and Asia-Pacific. The parasite forms dormant liver stages (hypnozoites) that reactivate weeks to months after an initial infection causing recurrent episodes of malaria (relapses). Multiple recurrences are a...

Full description

Bibliographic Details
Main Author: Price, RN
Format: Journal article
Language:English
Published: Elsevier 2024
_version_ 1826314372015718400
author Price, RN
author_facet Price, RN
author_sort Price, RN
collection OXFORD
description Plasmodium vivax causes a substantial burden of disease in the Americas, the Horn of Africa, and Asia-Pacific. The parasite forms dormant liver stages (hypnozoites) that reactivate weeks to months after an initial infection causing recurrent episodes of malaria (relapses). Multiple recurrences are associated with a cumulative risk of anaemia, significant morbidity, and mortality. An estimated 60–90% of vivax malaria cases are attributable to relapses, and these drive the ongoing transmission of the parasite. The elimination of both blood and liver stage parasite (known as radical cure) is crucial for the timely elimination of P vivax.
first_indexed 2024-04-09T03:55:52Z
format Journal article
id oxford-uuid:33bcc1b6-518f-42c6-811d-9092bdc05de4
institution University of Oxford
language English
last_indexed 2024-09-25T04:33:07Z
publishDate 2024
publisher Elsevier
record_format dspace
spelling oxford-uuid:33bcc1b6-518f-42c6-811d-9092bdc05de42024-09-05T09:09:52ZProgress towards safer and more effective radical cure of Plasmodium vivaxJournal articlehttp://purl.org/coar/resource_type/c_6501uuid:33bcc1b6-518f-42c6-811d-9092bdc05de4EnglishSymplectic ElementsElsevier2024Price, RNPlasmodium vivax causes a substantial burden of disease in the Americas, the Horn of Africa, and Asia-Pacific. The parasite forms dormant liver stages (hypnozoites) that reactivate weeks to months after an initial infection causing recurrent episodes of malaria (relapses). Multiple recurrences are associated with a cumulative risk of anaemia, significant morbidity, and mortality. An estimated 60–90% of vivax malaria cases are attributable to relapses, and these drive the ongoing transmission of the parasite. The elimination of both blood and liver stage parasite (known as radical cure) is crucial for the timely elimination of P vivax.
spellingShingle Price, RN
Progress towards safer and more effective radical cure of Plasmodium vivax
title Progress towards safer and more effective radical cure of Plasmodium vivax
title_full Progress towards safer and more effective radical cure of Plasmodium vivax
title_fullStr Progress towards safer and more effective radical cure of Plasmodium vivax
title_full_unstemmed Progress towards safer and more effective radical cure of Plasmodium vivax
title_short Progress towards safer and more effective radical cure of Plasmodium vivax
title_sort progress towards safer and more effective radical cure of plasmodium vivax
work_keys_str_mv AT pricern progresstowardssaferandmoreeffectiveradicalcureofplasmodiumvivax